Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

2012250 citationsJournal Articlebronze Open Access

Authors

Dharanija Madhavan · National Center for Tumor Diseases

Manuela Zucknick · Universität Hamburg

Markus Wallwiener · University Medical Center Hamburg-Eppendorf

Katarina Ćuk · Heidelberg Institute for Stem Cell Technology and Experimental Medicine

Caroline Modugno · National Center for Tumor Diseases

Martina Scharpff · Universität Hamburg

Sarah Schott

Abstract

This is the first study to document the capacity of circulating miRNAs to indicate CTC status and their potential as prognostic markers in patients with MBC.

Topics & Keywords

Cancer Cells and Metastasis MicroRNA in disease regulation Epigenetics and DNA Methylation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Cancer Research

Volume 18, Issue 21, pp. 5972-5982

DOI: 10.1158/1078-0432.ccr-12-1407

Field-Weighted Citation Impact: 13.44